3/12
09:50 am
vrtx
The Next Frontier Of Biohacking: Five Trends Poised To Redefine Health And Longevity [Forbes]
Low
Report
The Next Frontier Of Biohacking: Five Trends Poised To Redefine Health And Longevity [Forbes]
3/12
09:05 am
vrtx
Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio? [Yahoo! Finance]
Low
Report
Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio? [Yahoo! Finance]
3/11
11:07 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/11
07:31 am
vrtx
3 Reasons to Avoid VRTX and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons to Avoid VRTX and 1 Stock to Buy Instead [Yahoo! Finance]
3/7
10:02 am
vrtx
Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis
Low
Report
Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis
3/6
07:08 pm
vrtx
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial [Yahoo! Finance]
Low
Report
Tris Pharma eyes approval after pain drug triumphs in second Phase III trial [Yahoo! Finance]
3/4
12:21 pm
vrtx
Qureator Appoints Dr. Branka Mitrovic as Chief Scientific Officer [Yahoo! Finance]
Low
Report
Qureator Appoints Dr. Branka Mitrovic as Chief Scientific Officer [Yahoo! Finance]
2/28
08:02 am
vrtx
Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations [Yahoo! Finance]
Low
Report
Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations [Yahoo! Finance]
2/28
07:22 am
vrtx
Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations
Low
Report
Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations
2/25
06:16 am
vrtx
Sionna Therapeutics' IPO: A strategic shift in the cystic fibrosis market [Yahoo! Finance]
Low
Report
Sionna Therapeutics' IPO: A strategic shift in the cystic fibrosis market [Yahoo! Finance]
2/24
05:10 pm
vrtx
Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment [Yahoo! Finance]
Low
Report
Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment [Yahoo! Finance]
2/24
06:03 am
vrtx
Dr. Reshma Kewalramani [CNBC]
Low
Report
Dr. Reshma Kewalramani [CNBC]
2/24
06:03 am
vrtx
Kim A. Keck [CNBC]
Low
Report
Kim A. Keck [CNBC]
2/22
07:25 pm
vrtx
Struggling bluebird bio to go private for less than $30m [Yahoo! Finance]
Low
Report
Struggling bluebird bio to go private for less than $30m [Yahoo! Finance]
2/22
03:30 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was given a new $545.00 price target on by analysts at BMO Capital Markets.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was given a new $545.00 price target on by analysts at BMO Capital Markets.
2/20
11:56 am
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Royal Bank of Canada from $407.00 to $408.00. They now have a "sector perform" rating on the stock.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Royal Bank of Canada from $407.00 to $408.00. They now have a "sector perform" rating on the stock.
2/19
11:01 pm
vrtx
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
2/18
04:41 pm
vrtx
Vertex to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Low
Report
Vertex to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/18
04:05 pm
vrtx
Vertex to Participate in Upcoming March Investor Conferences
Low
Report
Vertex to Participate in Upcoming March Investor Conferences
2/16
07:15 am
vrtx
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US [Yahoo! Finance]
Low
Report
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US [Yahoo! Finance]
2/15
08:55 am
vrtx
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025 [Yahoo! Finance]
Low
Report
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025 [Yahoo! Finance]
2/15
07:17 am
vrtx
The Ultimate Healthcare Stock to Buy With $500 Right Now [Yahoo! Finance]
Low
Report
The Ultimate Healthcare Stock to Buy With $500 Right Now [Yahoo! Finance]
2/14
08:05 am
vrtx
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing [Yahoo! Finance]
2/13
05:31 pm
vrtx
Vertex Pharmaceuticals files automatic mixed securities shelf [Seeking Alpha]
Low
Report
Vertex Pharmaceuticals files automatic mixed securities shelf [Seeking Alpha]
2/13
05:14 pm
vrtx
Vertex Pharmaceuticals price target raised to $520 from $460 at Truist [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals price target raised to $520 from $460 at Truist [Yahoo! Finance]